Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Monday, July 6 2009 4:40am ET - U.S. Markets open in 4 hours and 50 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > Sanofi-Aventis Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Sanofi-Aventis Company Profile
Sanofi-Aventis helps docs treat their sneezy patients without making them grumpy or dopey. The maker of allergy medicine Allegra specializes in six therapeutic categories: internal medicine (including allergies), cardiovascular problems, thrombosis (blood clots), central nervous system disorders, cancer, and metabolic conditions. Its top sellers include blood thinners Plavix (which it markets with Bristol-Myers Squibb) and Lovenox, cancer drugs Taxotere and Eloxatine, insulin brand Lantus, and insomnia treatment Ambien. It is also one of the largest makers of vaccines through its Sanofi Pasteur subsidiary. The company is one of Europe's largest pharmaceutical companies.
Headlines for Sanofi-Aventis
[external] European media stocks make gains
at FT.com - Fri Jul 3
Sanofi-Aventis arrhythmia drug Multaq approved
AP - Thu Jul 2
Likely FDA Approval Gives Dendreon A Lift
Investor's Business Daily - Thu Jul 2
[external] At Last, a Heartening Drug Approval
at Motley Fool - Thu Jul 2
More Headlines...
More on Sanofi-Aventis
Quote Research
Chart Msgs
Profile Financials
Reports    
Contact Information
Address: 174 avenue de France
75013 Paris, France
Phone:+33-1-53-77-40-00
Fax:+33-1-53-77-43-03
Financial Highlights
Fiscal Year End:December
Revenue (2008):40617.60 M
Revenue Growth (1 yr):(-1.60%)
Employees (2008):98,213
Employee Growth (1 yr):(-1.30%)
Key People
Chairman: Jean-François Dehecq
CEO: Chris Viehbacher
EVP and CFO: Jérôme Contamine
Industry Information
Sector: Healthcare
Industry: Drug Manufacturers - Major
Top Competitors
GlaxoSmithKline plc (gsk)
Merck & Co., Inc. (mrk)
Pfizer Inc. (pfe)
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?